MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics Statistics

Total Valuation

INKT has a market cap or net worth of $55.30 million. The enterprise value is $46.74 million.

Market Cap	55.30M
Enterprise Value	46.74M

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026, before market open.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

INKT has 4.69 million shares outstanding. The number of shares has increased by 12.09% in one year.

Current Share Class	4.69M
Shares Outstanding	4.69M
Shares Change (YoY)	+12.09%
Shares Change (QoQ)	+11.58%
Owned by Insiders (%)	17.89%
Owned by Institutions (%)	1.83%
Float	1.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.08

Current Ratio	1.08
Quick Ratio	1.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-69.61%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-812.97%
Weighted Average Cost of Capital (WACC)	5.55%
Revenue Per Employee	n/a
Profits Per Employee	-$537,185
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.49% in the last 52 weeks. The beta is 0.34, so INKT's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+78.49%
50-Day Moving Average	11.82
200-Day Moving Average	12.39
Relative Strength Index (RSI)	44.56
Average Volume (20 Days)	10,753

Short Selling Information

The latest short interest is 31,835, so 0.68% of the outstanding shares have been sold short.

Short Interest	31,835
Short Previous Month	32,992
Short % of Shares Out	0.68%
Short % of Float	1.90%
Short Ratio (days to cover)	1.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.44M
Pretax Income	-12.36M
Net Income	-12.36M
EBITDA	-12.24M
EBIT	-12.44M
Earnings Per Share (EPS)	-$3.02

Balance Sheet

The company has $14.28 million in cash and $5.73 million in debt, with a net cash position of $8.56 million or $1.82 per share.

Cash & Cash Equivalents	14.28M
Total Debt	5.73M
Net Cash	8.56M
Net Cash Per Share	$1.82
Equity (Book Value)	-13.51M
Book Value Per Share	-2.94
Working Capital	1.10M

Cash Flow

Operating Cash Flow	-5.58M
Capital Expenditures	n/a
Free Cash Flow	-5.58M
FCF Per Share	-$1.19

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.09%
Shareholder Yield	-12.09%
Earnings Yield	-22.34%
FCF Yield	-10.09%

Analyst Forecast

The average price target for INKT is $35.00, which is 197.11% higher than the current price. The consensus rating is "Buy".

Price Target	$35.00
Price Target Difference	197.11%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 28, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 28, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2